HomeAboutRankingsData Sources
Β© 2026 GeneE
🧬
GeneE
10 sources retrieved Β· Most recent: April 2026 Β· Index updated 14 days ago
β“˜GeneE is for informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment.
SLURP1
secreted LY6/PLAUR domain containing 1
Chromosome 8 Β· 8q24.3
NCBI Gene: 57152Ensembl: ENSG00000126233.2HGNC: HGNC:18746UniProt: P55000
55PubMed Papers
21Diseases
0Drugs
14Pathogenic Variants
CLINICAL
OMIM Disease Gene
DATA QUALITY
βœ“ Experimental GO Evidenceβœ“ Swiss-Prot Reviewed
urokinase plasminogen activator signaling pathwayprotein bindingGO:0005615extracellular exosomemal de MeledaPalmoplantar keratodermadiffuse palmoplantar keratodermadermatophytosis
✦AI Summary

SLURP1 encodes a secreted protein that functions as a multifaceted regulator of cellular homeostasis and immune responses. The protein serves as an allosteric inhibitor of Ξ±7 nicotinic acetylcholine receptors, modulating calcium signaling and cellular proliferation 1. In skin physiology, SLURP1 is essential for maintaining keratinocyte differentiation and structural integrity, with its loss causing palmoplantar keratoderma through disruption of ER-based mechano-resistance mechanisms involving SERCA2b calcium pumps 2. The protein exhibits significant anti-tumor activity across multiple cancer types, including colorectal and bladder cancers, by inhibiting cell proliferation, inducing cell cycle arrest at G1/S interface, and modulating inflammatory responses through NF-ΞΊB signaling 34. SLURP1 also functions as a protective antioxidant factor in corneal epithelium, upregulating antioxidant enzymes and suppressing ROS accumulation to maintain redox homeostasis 5. Disease associations include autosomal recessive Mal de Meleda from loss-of-function mutations and newly identified autosomal dominant progressive symmetric erythrokeratoderma from signal peptide variants that exhibit dominant-negative effects 67. The protein's diverse functions position it as both a therapeutic target and biomarker for cancer prognosis.

Sources cited
1
SLURP1 functions as allosteric inhibitor of Ξ±7 nicotinic acetylcholine receptors
PMID: 26905431
2
SLURP1 maintains keratinocyte differentiation through ER-based mechano-resistance mechanisms involving SERCA2b
PMID: 40763735
3
SLURP1 exhibits anti-tumor activity by inhibiting cell proliferation and modulating NF-ΞΊB signaling
PMID: 37896222
4
SLURP1 identified as potential therapeutic target for bladder cancer
PMID: 39707285
5
SLURP1 protects corneal epithelium by upregulating antioxidants and suppressing ROS accumulation
PMID: 40094657
6
Signal peptide variants in SLURP1 cause autosomal dominant progressive symmetric erythrokeratoderma
PMID: 40023748
7
Autosomal dominant SLURP1 variants cause palmoplantar keratoderma through dominant-negative effects
PMID: 39913669
Disease Associationsβ“˜21
mal de MeledaOpen Targets
0.81Strong
Palmoplantar keratodermaOpen Targets
0.37Weak
diffuse palmoplantar keratodermaOpen Targets
0.37Weak
dermatophytosisOpen Targets
0.25Weak
subarachnoid hemorrhageOpen Targets
0.15Weak
neoplasmOpen Targets
0.10Weak
interstitial lung diseaseOpen Targets
0.09Suggestive
posterior cortical atrophyOpen Targets
0.08Suggestive
gastric carcinomaOpen Targets
0.08Suggestive
dermatomyositisOpen Targets
0.07Suggestive
esophageal adenocarcinomaOpen Targets
0.06Suggestive
idiopathic interstitial pneumoniaOpen Targets
0.06Suggestive
breast cancerOpen Targets
0.05Suggestive
benign prostatic hyperplasiaOpen Targets
0.05Suggestive
cancerOpen Targets
0.04Suggestive
psoriasisOpen Targets
0.04Suggestive
Alzheimer diseaseOpen Targets
0.04Suggestive
myositisOpen Targets
0.04Suggestive
asthmaOpen Targets
0.04Suggestive
ossification of the posterior longitudinal ligament of the spineOpen Targets
0.04Suggestive
Mal de MeledaUniProt
Pathogenic Variants14
NM_020427.3(SLURP1):c.82del (p.Cys28fs)Pathogenic
Acroerythrokeratoderma|not provided
β˜…β˜…β˜†β˜†2025β†’ Residue 28
NM_020427.3(SLURP1):c.286C>T (p.Arg96Ter)Pathogenic
Acroerythrokeratoderma|not provided
β˜…β˜…β˜†β˜†2025β†’ Residue 96
NM_020427.3(SLURP1):c.43T>C (p.Trp15Arg)Pathogenic
Acroerythrokeratoderma|not provided
β˜…β˜…β˜†β˜†2025β†’ Residue 15
NM_020427.3(SLURP1):c.59-1G>ALikely pathogenic
not provided
β˜…β˜†β˜†β˜†2024
NM_020427.3(SLURP1):c.1A>C (p.Met1Leu)Likely pathogenic
Acroerythrokeratoderma
β˜…β˜†β˜†β˜†2024β†’ Residue 1
NM_020427.3(SLURP1):c.240_246delinsAG (p.Asp81fs)Likely pathogenic
not provided
β˜…β˜†β˜†β˜†2024β†’ Residue 81
NM_020427.3(SLURP1):c.256G>A (p.Gly86Arg)Pathogenic
Acroerythrokeratoderma|not provided
β˜…β˜†β˜†β˜†2022β†’ Residue 86
NM_020427.3(SLURP1):c.178G>A (p.Glu60Lys)Likely pathogenic
not provided
β˜…β˜†β˜†β˜†2017β†’ Residue 60
NM_020427.3(SLURP1):c.111C>A (p.Cys37Ter)Likely pathogenic
Acroerythrokeratoderma
β˜…β˜†β˜†β˜†β†’ Residue 37
NM_020427.3(SLURP1):c.256G>C (p.Gly86Arg)Pathogenic
Acroerythrokeratoderma
β˜†β˜†β˜†β˜†2025β†’ Residue 86
NM_020427.3(SLURP1):c.229T>C (p.Cys77Arg)Pathogenic
Acroerythrokeratoderma
β˜†β˜†β˜†β˜†2004β†’ Residue 77
NM_020427.3(SLURP1):c.296G>A (p.Cys99Tyr)Pathogenic
Acroerythrokeratoderma
β˜†β˜†β˜†β˜†2004β†’ Residue 99
NM_020427.3(SLURP1):c.178+1G>APathogenic
Acroerythrokeratoderma
β˜†β˜†β˜†β˜†2001
NM_020427.3(SLURP1):c.243C>A (p.Asp81Glu)Pathogenic
Acroerythrokeratoderma
β˜†β˜†β˜†β˜†β†’ Residue 81
View on ClinVar β†—
Related Genes
LYNX1Protein interaction97%SLURP2Protein interaction97%LYPD6Protein interaction95%LYPD1Protein interaction80%CHRNA9Protein interaction75%LY6HProtein interaction72%
Tissue Expression6 tissues
Liver
100%
Ovary
60%
Lung
40%
Brain
20%
Heart
0%
Bone Marrow
0%
Gene Interaction Network
Click a node to explore
SLURP1LYNX1SLURP2LYPD6LYPD1CHRNA9LY6H
PROTEIN STRUCTURE
Preparing viewer…
PDB6ZZE Β· NMR
View on RCSB β†—
Constraintβ“˜
LOEUFβ“˜
1.03LoF Tolerant
pLIβ“˜
0.22Tolerant
Observed/Expected LoF0.45 [0.22–1.03]
RankingsWhere SLURP1 stands among ~20K protein-coding genes
  • #8,251of 20,598
    Most Researched55
  • #2,529of 5,498
    Most Pathogenic Variants14
  • #10,207of 17,882
    Most Constrained (LOEUF)1.03
Genes detectedSLURP1
Sources retrieved10 papers
Response timeβ€”
πŸ“„ Sources
10β–Ό
1
Targeting MAPK14 by Lobeline Upregulates Slurp1-Mediated Inhibition of Alternative Activation of TAM and Retards Colorectal Cancer Growth.
PMID: 39840525
Adv Sci (Weinh) Β· 2025
1.00
2
A mechano-resistance mechanism in skin adapts to terrestrial locomotion.
PMID: 40763735
Cell Β· 2025
0.90
3
Autosomal dominant SLURP1 variants cause palmoplantar keratoderma and progressive symmetric erythrokeratoderma.
PMID: 39913669
Br J Dermatol Β· 2025
0.80
4
Inflammation-Related Immune-Modulatory SLURP1 Prevents the Proliferation of Human Colon Cancer Cells, and Its Delivery by
PMID: 37896222
Pharmaceutics Β· 2023
0.70
5
Emerging Role of Lymphocyte Antigen-6 Family of Genes in Cancer and Immune Cells.
PMID: 31068932
Front Immunol Β· 2019
0.60